Telix Pharmaceuticals (Belgium) SRL
51.0 FTETelix Pharmaceuticals (Belgium) reported revenue of €14.9m for the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 51 full-time equivalents.
By total assets for 2025, Telix Pharmaceuticals (Belgium) ranks among the 50 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Telix Pharmaceuticals (Belgium) shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +539 % Equity -25 % Total assets +336 % Headcount (avg FTE) +275 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Telix Pharmaceuticals (Belgium)'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €14.9m | ||||
| Net result | −54,903 € | ||||
| Equity | 515,466 € | ||||
| Cash | €1.90m | ||||
| EBITDA | €1.84m | ||||
| Total assets | €57.1m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Telix Pharmaceuticals (Belgium)'s financial analysis
- Solvency0.9%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Telix Pharmaceuticals (Belgium)
Telix Pharmaceuticals (Belgium)'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0695.832.765
- VAT number
- BE0695832765
- Peppol
- Registered · 0208:0695832765 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 May 2018
- Registered office
- 7180 Seneffe
- Size
- Medium · 51.0 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Telix Pharmaceuticals (Belgium) (SRL) has been based in Seneffe since 2018, active in: manufacture of other pharmaceutical products. For 2025, it reports revenue of €14.9m, a net loss of 54,903 € and equity of 515,466 €. With 51.0 full-time equivalents, it is a medium-sized enterprise by headcount.
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Telix Pharmaceuticals (Belgium)
Companies in the same business, of comparable size and area, outside its group.
- IRE ELiT Manufacture of pharmaceutical preparations Fleurus · balance sheet €19.5m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- Medgenix Benelux Manufacture of pharmaceutical preparations Wevelgem · balance sheet €39.4m
- PanTera Manufacture of pharmaceutical preparations Mol · balance sheet €115.8m
- Eli Lilly European Clinical Trial Services Manufacture of medical and dental instruments and supplies Mont-Saint-Guibert · balance sheet €57.4m
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- Estetra Research and experimental development on natural sciences and engineering Liège · balance sheet €66.6m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
Frequently asked questions about Telix Pharmaceuticals (Belgium)
What is the revenue of Telix Pharmaceuticals (Belgium)?
According to the 2025 annual accounts filed with the NBB, the revenue of Telix Pharmaceuticals (Belgium) amounts to 14,873,793 €.
What is the VAT number of Telix Pharmaceuticals (Belgium)?
In Belgium, the VAT number is the company number prefixed with BE: BE0695832765 for Telix Pharmaceuticals (Belgium), if the company is VAT-registered. Its company number (CBE) is 0695.832.765.
Where is the registered office of Telix Pharmaceuticals (Belgium)?
According to the CBE register, the registered office of Telix Pharmaceuticals (Belgium) is in 7180 Seneffe.
What is the equity of Telix Pharmaceuticals (Belgium)?
At the close of the 2025 financial year, the equity of Telix Pharmaceuticals (Belgium) amounts to 515,466 €, a solvency of 0.9% of total assets.
How many people work at Telix Pharmaceuticals (Belgium)?
51.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Telix Pharmaceuticals (Belgium)?
The register lists 2 active mandates at Telix Pharmaceuticals (Belgium). Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Telix Pharmaceuticals (Belgium) within its sector?
By total assets for 2025, Telix Pharmaceuticals (Belgium) ranks among the 50 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of Telix Pharmaceuticals (Belgium)
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →